Ovarian cancer guidelines: Treatment progress and controversies

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 9, Issue 1, 2011, Pages 4-5

  Morgan Jr , Robert J ^a,b,c  

^a Department of Medical Oncology and Therapeutics Research ^*  (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL TRIAL (TOPIC); CYTOREDUCTIVE SURGERY; HUMAN; META ANALYSIS (TOPIC); MINIMALLY INVASIVE SURGERY; NOTE; OVARY CANCER; PRACTICE GUIDELINE; TREATMENT OUTCOME;

EID: 78951487149     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2011.0002     Document Type: Note

References (0)